Meet us at the ACS National Meeting in Orlando, USA (link to conference website) - Mar 31, 2019 - Apr 04, 2019
The ACS organizes two national meetings & expositions each year, and each one attracts an estimated 11,000 to 13,000 chemists, chemical engineers, academicians, graduate and undergraduate students, and other related professionals. During the meeting, scientists present new multidisciplinary research, hear the latest information in their areas of professional interest, and network with colleagues.
Presentation from Stefan Geschwindner (AstraZeneca) at the 6th edition of NovAliX conference, including data on our collaboration on challenging membrane protein targets with Salipro® and SPR.
Salipro Biotech signs multi-target agreement with an additional global pharma company. Salipro Biotech will apply its expertise and its unique membrane protein technology to advance programs on challenging targets selected by the pharmaceutical partner.
Out now: Salipro® goes Biacore™ systems - See the results of our collaboration with GE Healthcare on antibody binding to membrane proteins, detergent-free, in our Application Note (link)
Salipro Biotech receives “Groundbreaking Idea Grant” from the Swedish Innovation Agency for the development of therapeutic antibodies.
Salipro Biotech receives notice of allowance from U.S. Patent and Trademark Office relevant to its Salipro® technology for the stabilisation of drug targets
Salipro Biotech received the poster award at the GE Healthcare DiPIA in Boston.
Meet us at the GE Healthcare DiPIA meeting in Boston (June 17-20), presenting a poster with the results of our collaboration with GE Healthcare.
Salipro® for functional studies of a GPCR with NMR. Half-life of GPCR in Salipro® extended from 1.5 to 30 days. Check out the latest paper on our technology by Nietlispach et al: http://pubs.acs.org/doi/10.1021/jacs.7b06730
CEO Jens Frauenfeld invited speaker at the 10th Annual Proteins & Antibodies Congress in London.